Skip to main content

Cannabis sales grow in Israel

The Lod-based company Panaxia reported increased revenues from the Israeli market for its sales of medical cannabis in 2021.

Israel cannabis
A worker checks plants at a greenhouse of Israeli company B.O.L Pharma, which makes medical cannabis products, near Moshav Yad Binyamin in southern Israel on Feb. 1, 2022. — MENAHEM KAHANA/AFP via Getty Images

The Israeli cannabis company Panaxia released its earnings for 2021 Tuesday. 

Panaxia, which is based in the mixed Arab-Jewish city of Lod, said its net Israeli revenues increased 38% to $83.6 million, according to a press release. 

Subscribe for unlimited access

All news, events, memos, reports, and analysis, and access all 10 of our newsletters. Learn more

$14 monthly or $100 annually ($8.33/month)
OR

Continue reading this article for free

All news, events, memos, reports, and analysis, and access all 10 of our newsletters. Learn more.

By signing up, you agree to Al-Monitor’s Terms and Conditions and Privacy Policy. Already have an account? Log in